RHABDOMYOSARCOMA

This adverse event was reported 188 times

These drugs are most commonly taken by patients reporting RHABDOMYOSARCOMA:

# Drug Count
0 CYCLOPHOSPHAMIDE 24
1 CYCLOPHOSPHAMIDE FOR INJECTION 24
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 24
3 ETOPOSIDE 17
4 IFOSFAMIDE 15
5 IFOSFAMIDE FOR INJECTION 15
6 DOXORUBICIN 14
7 CARBOPLATIN 11
8 LAMIVUDINE 11
9 LAMIVUDINE ORAL 11
See all common drugs associated with RHABDOMYOSARCOMA

RHABDOMYOSARCOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DACTINOMYCIN 9 0.0041
1 FAMOTIDINE 20MG 1 0.0027
2 SODIUM MONOFLUOROPHOSPHATE 1 0.0027
3 DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE 1 0.0023
4 PEGFILGRASTIM-CBQV 2 0.0014
5 ZIDOVUDINE 11 0.0011
6 DEXRAZOXANE FOR INJECTION 1 0.0011
7 IFOSFAMIDE FOR INJECTION 15 0.0007
8 SAXAGLIPTIN 1 0.0007
9 TOPOTECAN 4 0.0007
See all drugs enriched for association with RHABDOMYOSARCOMA